The effect of evening primrose oil in the treatment of multiple sclerosis
Not Applicable
- Conditions
- Multiple sclerosis.Demyelinating diseases of the central nervous systemG35-G37
- Registration Number
- IRCT2015101324520N1
- Lead Sponsor
- Vice Chancellor For Research Of Jundishapur University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1) The diagnosis of the neurological examination and magnetic resonance imaging confirmed by a doctor neurologist is sent. 2) persons 15-55 years 3) EDSS score of less than 6, 4) neurological diseases such as stroke or psychiatric, such as depression or not. 5) pregnant women are not tested. 6) autoimmune diseases like lupus or rheumatoid arthritis, and heart as Bdkhymy- not. 7) patients in the last month attack (attack) is not new and they did not use the pulse corticosteroids.; Exclusion criteria: 1) the emergence of drug complications 2) resentment of the presence in the study 3) of the drug for a week 4) Pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: Before and 3 months after intervention. Method of measurement: Quality of Life in this study using a questionnaire with 54 questions were Vickrey and colleagues. sclerosis.
- Secondary Outcome Measures
Name Time Method Fatigue. Timepoint: Before and 3 months after intervention. Method of measurement: MFIS was measured using the scale of fatigue in multiple sclerosis.